U.S. House Passes Drug Pricing Bill

Dec. 13, 2019 — A U.S. House Democrat charge that would give Medicare the authority to arrange prescription drug costs and provide modern benefits for seniors was passed Thursday in a 230-192 vote along party lines.

In any case, the bill has no chance of being passed by the Republican-controlled Senate and the White House has threatened to reject it, the Related Press detailed.

The AARP is among the groups that support the charge, while the pharmaceutical industry strongly restricts it.

House Speaker Nancy Pelosi’s charge would limit Medicare patients‘ out-of-pocket costs for medicines to $2,000 a year and make coverage for dental care, hearing and vision by using the $360 billion of anticipated 10-year investment funds from lower drug costs, the AP reported.

The charge „may be a serious proposal but everyone knows that the Senate isn’t reaching to go for it,“ according to John Rother, CEO of the National Coalition on Wellbeing, a bunch that speaks to wellbeing care industry bunches and customers.

„It is around administering, but even more it’s approximately setting up a stage that Democrats can run on going into the following decision cycle and lays the foundation for authoritative movement in 2021,“ Rother told the AP.

Pelosi said her bill would provide on Donald Trump’s promise during the 2016 presidential campaign to „arrange like crazy“ to lower prescription sedate prices for Medicare recipients.

As president, Trump has sponsored absent from the promise, the AP reported.

Kamagra Oral Jelly Miglior Prezzo

Schreibe einen Kommentar

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert.